4//SEC Filing
Collins Helen Louise 4
Accession 0000950170-25-083041
CIK 0001422143other
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 4:05 PM ET
Size
5.2 KB
Accession
0000950170-25-083041
Insider Transaction Report
Form 4
Collins Helen Louise
Director
Transactions
- Award
Option to purchase common stock
2025-06-05+28,500→ 28,500 totalExercise: $6.57Exp: 2035-06-04→ Common Stock (28,500 underlying)
Footnotes (1)
- [F1]This option vests in full on the one year anniversary of the date of grant.
Documents
Issuer
Kura Oncology, Inc.
CIK 0001422143
Entity typeother
Related Parties
1- filerCIK 0001701247
Filing Metadata
- Form type
- 4
- Filed
- Jun 5, 8:00 PM ET
- Accepted
- Jun 6, 4:05 PM ET
- Size
- 5.2 KB